RecallRadar

FDA Drug recall D-0437-2017

Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31

On 2017-02-01 the FDA classified a Class II recall of Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31 by Roxane Laboratories, citing failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0437-2017
ClassificationClass II
Statusterminated
Initiated2016-12-22
Published2017-02-01
Last updated2026-09-13 11:51 UTC
CompanyRoxane Laboratories
DistributionUS

Product

Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31.

Reason

Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

Identifiers

ndc0054-4297-31
ndc0054-4297-25
ndc0054-8297-25
ndc0054-4299-31
ndc0054-4299-25
ndc0054-8299-25
ndc0054-4301-29
ndc0054-4301-25
ndc0054-8301-25
ndc0054-3298-63
ndc0054-3294-50
ndc0054-3294-46
code_infoLot# 660833A, Exp 08/31/18

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0437-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.